Impact of Intestinal Rehabilitation Program and Its Innovative Therapies on the Outcome of Intestinal Transplant Candidates

• Published in: Journal of pediatric gastroenterology and nutrition Vol. 61; no. 1; pp. 18 - 23
• Main Authors: Avitzur, Yaron, Wang, Jenny Y., Silva, Nicole T., Burghardt, Karolina M., DeAngelis, Maria, Grant, David, Ng, Vicky L., Jones, Nicola, Wales, Paul W.
• Format: Journal Article
• Language: English
• Published: United States by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology 01.07.2015
• Subjects: Child; Child, Preschool; Female; Humans; Infant; Intestinal Diseases - surgery; Intestinal Diseases - therapy; intestinal failure; intestinal rehabilitation; intestinal transplantation; Intestines - pathology; Intestines - surgery; Male; Organ Transplantation; program; Retrospective Studies; Therapies, Investigational; therapy; Waiting Lists
• ISSN: 0277-2116; 1536-4801
• DOI: 10.1097/MPG.0000000000000735

ABSTRACT Objectives: The outcome of children with intestinal failure has improved during the past decade following the introduction of novel therapies by dedicated intestinal rehabilitation programs (IRP). The aim of the present study was to assess the impact of IRP on the outcome of intestinal transplant (IT) candidates and the transplant waiting list. Methods: A retrospective cohort study of children assessed for IT (n = 84) during a 10‐year period. Comparisons were made among the following 3 time periods: before the establishment of our center's IRP (1999–2002; n = 33), early IRP (2003–2005; n = 18), and late IRP (2006–2009; n = 33). The following endpoints were used: patient outcome following IT assessment (not listed, listed and removed from the list, received transplant, died while on the list), patient characteristics at IT assessment, and patient status at the end of the study. Results: The late‐IRP era was associated with an increase in patients who were not listed (42% vs 28% at other periods, P = NS) and patients who were removed from the IT waiting list because of clinical improvement (P < 0.0005), and a decrease in those who died before transplant (15% vs >60% at other periods, P < 0.0005). The cause of death shifted from traditional causes such as liver failure or sepsis to other comorbid conditions (P < 0.005). Improved liver function at listing was also observed during late IRP (P < 0.005). Conclusions: Treatment by IRP, coupled with recent advances in the medical management of intestinal failure, is associated with improved survival and outcome of patients waiting for IT, and may lead to overall reduction in the number of IT in the future.